Your Comments On...

Pfizer Shares Sink as It Halts Plans for Cholesterol Drug

NEW YORK, Dec. 4 -- Shares of Pfizer, the world's largest drug maker, sank Monday on news that the company had halted development of a key new cholesterol treatment that was heralded as the engine to reignite the company's stagnant sales.
 - 

By Theresa Agovino